Ranitidine and Amikacin sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Amikacin sulfate (amikacin sulfate). Common drug interactions include diarrhoea among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Amikacin sulfate. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Amikacin sulfate?

Amikacin sulfate has active ingredients of amikacin sulfate. eHealthMe is studying from 2,538 Amikacin sulfate users. Check the latest studies of Amikacin sulfate.



On Jul, 19, 2026

26 people who take Ranitidine and Amikacin sulfate together, and have interactions are studied.

Ranitidine and Amikacin sulfate drug interactions.

What are the common drug interactions of Ranitidine and Amikacin Sulfate, by gender? *:

female:

  1. Diarrhoea
  2. Performance status decreased
  3. Dysgeusia (disorder of the sense of taste)
  4. Hypokalaemia (low potassium)
  5. Nausea (feeling of having an urge to vomit)
  6. Arthralgia (joint pain)
  7. Dysaesthesia (abnormal sensation)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Fatigue (feeling of tiredness)
  10. Febrile neutropenia (fever with reduced white blood cells)

male:

  1. Anaemia (lack of blood)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Fluid intake reduced
  4. Glossitis (infection of tongue with soreness)
  5. Haematochezia (passage of stools containing blood)
  6. Mucous stools (mucous with stool)
  7. Pyrexia (fever)
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Vomiting
  10. Presyncope

What are the common drug interactions of Ranitidine and Amikacin Sulfate, by age (0-1 to 60+)? *:

0-1:

  1. Primary immunodeficiency syndrome
  2. Chronic granulomatous disease (immune system cells are unable to kill some types of bacteria and fungi)
  3. Fluid intake reduced

2-9:

n/a

10-19:

  1. Anaemia (lack of blood)
  2. Intestinal perforation (complete penetration of the wall of the intestine)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Presyncope
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  7. Arthralgia (joint pain)
  8. Bone marrow failure
  9. Capillary leak syndrome (capillary leaks plasma)
  10. Constipation

20-29:

n/a

30-39:

n/a

40-49:

  1. Malaise (a feeling of general discomfort or uneasiness)

50-59:

  1. Oral candidiasis (fungal infection of mouth)
  2. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)

60+:

  1. Diarrhoea
  2. Performance status decreased
  3. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  4. Bone pain
  5. Skin toxicity (skin damage due to toxin/poison)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Infection
  8. Renal failure acute (rapid kidney dysfunction)
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  10. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. High Blood Pressure: 7 people, 26.92%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 23.08%
  3. Skin Toxicity (skin damage due to toxin/poison): 6 people, 23.08%
  4. Hypokalemia (low potassium): 4 people, 15.38%
  5. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 15.38%
  6. Taste - Impaired: 3 people, 11.54%
  7. Swallowing Difficulty: 3 people, 11.54%
  8. Nausea (feeling of having an urge to vomit): 3 people, 11.54%
  9. Breast Cancer: 3 people, 11.54%
  10. Mycobacterial Infection: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Amikacin sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Amikacin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amikacin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amikacin sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and amikacin sulfate (the active ingredients of Ranitidine and Amikacin sulfate, respectively), and Ranitidine and Amikacin sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: